Glaucoma Eye Drop Instillation: Impact of Education
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01416415|
Recruitment Status : Terminated (Not practical to continue due interim results)
First Posted : August 15, 2011
Last Update Posted : April 5, 2018
|Condition or disease||Intervention/treatment||Phase|
|Glaucoma, Open-Angle||Other: Video education on proper eye drop instillation technique Other: Placebo video education on healthy eating tips||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||119 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Outcomes Assessor)|
|Primary Purpose:||Supportive Care|
|Official Title:||Glaucoma Eye Drop Instillation: Impact of Education|
|Study Start Date :||August 2011|
|Actual Primary Completion Date :||June 2013|
|Actual Study Completion Date :||June 2013|
Experimental: Educational intervention
The educational intervention arm will contain subjects who will watch a video on proper eye drop instillation technique.
Other: Video education on proper eye drop instillation technique
The video is approximately seven minutes long and teaches the Robert Ritch method of instilling eye drops.
Placebo Comparator: Attention placebo
The attention control placebo group will receive an educational intervention that mimics the amount of time and attention received by the treatment group. The video chosen is regarding healthy eating tips.
Other: Placebo video education on healthy eating tips
The video is approximately seven minutes long and teaches tips to promote healthy eating.
- Eye drop instillation score [ Time Frame: 4 +/- 3 months ]The eye drop instillation score is a composite score of the efficacy, safety, and efficiency with which the subject instills their eyedrops and is simply a measure of how well the subject administers their eyedrops.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01416415
|United States, Illinois|
|Northwestern Medical Faculty Foundation|
|Chicago, Illinois, United States, 60611|
|Principal Investigator:||Angelo P Tanna, M.D.||Northwestern University Department of Ophthalmology|